Authors:
DEININGER MWN
BOSE S
GARATYBOR J
YAN XH
GOLDMAN JM
MELO JV
Citation: Mwn. Deininger et al., SELECTIVE INDUCTION OF LEUKEMIA-ASSOCIATED FUSION GENES BY HIGH-DOSE IONIZING-RADIATION, Cancer research, 58(3), 1998, pp. 421-425
Citation: Mwn. Deininger et al., IDENTIFICATION OF BCR-ABL TARGET GENES USING A DIFFERENTIAL DISPLAY APPROACH, British Journal of Haematology, 102(1), 1998, pp. 155-155
Authors:
BOSE S
DEININGER M
GORATYBOR J
GOLDMAN JM
MELO JV
Citation: S. Bose et al., THE PRESENCE OF TYPICAL AND ATYPICAL BCR-ABL FUSION GENES IN LEUKOCYTES OF NORMAL INDIVIDUALS - BIOLOGIC SIGNIFICANCE AND IMPLICATIONS FOR THE ASSESSMENT OF MINIMAL RESIDUAL DISEASE, Blood, 92(9), 1998, pp. 3362-3367
Authors:
HOCHHAUS A
YAN XH
WILLER A
HEHLMANN R
GORDON MY
GOLDMAN JM
MELO JV
Citation: A. Hochhaus et al., EXPRESSION OF INTERFERON REGULATORY FACTOR (IRF) GENES AND RESPONSE TO INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA, Leukemia, 11(7), 1997, pp. 933-939
Authors:
SPENCER A
VULLIAMY T
KAEDA J
GOLDMAN JM
MELO JV
Citation: A. Spencer et al., CLONAL INSTABILITY PRECEDING LYMPHOID BLASTIC TRANSFORMATION OF CHRONIC MYELOID-LEUKEMIA, Leukemia, 11(2), 1997, pp. 195-201
Citation: Mwn. Deininger et al., THE TYROSINE KINASE INHIBITOR CGP57148B SELECTIVELY INHIBITS THE GROWTH OF BCR-ABL-POSITIVE CELLS, Blood, 90(9), 1997, pp. 3691-3698
Authors:
GORATYBOR J
DEININGER M
GOLDMAN JM
MELO JV
Citation: J. Goratybor et al., THE SUSCEPTIBILITY OF CML CELLS TO FAS (CD95) MEDIATED APOPTOSIS IS INDEPENDENT OF THE ACTIVITY OF THE BCR-ABL TYROSINE KINASE, Blood, 90(10), 1997, pp. 358-358
Citation: M. Deininger et al., THE INDUCTION OF APOPTOSIS IN CML CELLS EXPOSED TO THE TYROSINE KINASE INHIBITOR CGP57148B IS ASSOCIATED WITH ALTERED GENE-TRANSCRIPTION, Blood, 90(10), 1997, pp. 360-360
Authors:
DEININGER WN
BOSE S
GORATYBOR J
YAN XH
GOLDMAN JM
MELO JV
Citation: Wn. Deininger et al., SELECTIVE INDUCTION OF LEUKEMIA-ASSOCIATED FUSION GENES BY HIGH-DOSE IONIZING-RADIATION, Blood, 90(10), 1997, pp. 1426-1426
Authors:
MELO JV
BOSE S
GORATYBOR J
DEININGER M
GOLDMAN JM
Citation: Jv. Melo et al., DETECTION OF LEUKEMIA-ASSOCIATED FUSION GENES IN LEUKOCYTES FROM NORMAL PEOPLE AND HEMATOPOIETIC-CELL LINES USING AN IMPROVED RT PCR ASSAY/, Blood, 90(10), 1997, pp. 2233-2233
Authors:
MELO JV
YAN XH
DIAMOND J
LIN F
CROSS NCP
GOLDMAN JM
Citation: Jv. Melo et al., REVERSE TRANSCRIPTION POLYMERASE CHAIN-REACTION (RT/PCR) AMPLIFICATION OF VERY SMALL NUMBERS OF TRANSCRIPTS - THE RISK IN MISINTERPRETING NEGATIVE RESULTS/, Leukemia, 10(7), 1996, pp. 1217-1221
Authors:
SPENCER A
YAN XH
CHASE A
GOLDMAN JM
MELO JV
Citation: A. Spencer et al., BCR-ABL-POSITIVE LYMPHOBLASTOID-CELLS DISPLAY LIMITED PROLIFERATIVE CAPACITY UNDER IN-VITRO CULTURE CONDITIONS, British Journal of Haematology, 94(4), 1996, pp. 654-658
Citation: Jv. Melo et al., LACK OF CORRELATION BETWEEN ABL-BCR EXPRESSION AND RESPONSE TO INTERFERON-ALPHA IN CHRONIC MYELOID-LEUKEMIA, British Journal of Haematology, 92(3), 1996, pp. 684-686
Authors:
HOCHHAUS A
REITER A
SKLADNY H
MELO JV
SICK C
BERGER U
GUO JQ
ARLINGHAUS RB
HEHLMANN R
GOLDMAN JM
CROSS NCP
Citation: A. Hochhaus et al., A NOVEL BCR-ABL, FUSION GENE (E6A2) IN A PATIENT WITH PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA, Blood, 88(6), 1996, pp. 2236-2240
Citation: M. Deininger et al., THE TYROSINE KINASE INHIBITOR CGP-57148 SELECTIVELY INHIBITS HEMATOPOIETIC COLONY FORMATION BY CML PROGENITOR CELLS OVER A 2-LOG DOSE RANGE, Blood, 88(10), 1996, pp. 1444-1444
Citation: M. Deininger et al., BCR-ABL POSITIVE CELL-LINES SHOW DIFFERENTIAL SENSITIVITY TO THE EFFECTS OF THE TYROSINE KINASE INHIBITOR CGP-57148, Blood, 88(10), 1996, pp. 1445-1445
Authors:
HOCHHAUS A
CROSS NCP
HEHLMANN R
GOLDMAN JM
MELO JV
Citation: A. Hochhaus et al., INTRONIC SEQUENCES OF THE ABL GENE ARE FREQUENTLY SPLICED INTO BCR-ABL, ABL-BCR, AND ABL TRANSCRIPTS FROM PATIENTS WITH CML AND IN ABL TRANSCRIPTS FROM NORMAL INDIVIDUALS, Blood, 88(10), 1996, pp. 2288-2288
Citation: Mi. Garin et al., EX-VIVO EXPANSION OF HUMAN HEMATOPOIETIC-CELLS FROM NORMAL BONE-MARROW AND PERIPHERAL-BLOOD FROM CML PATIENTS, Blood, 88(10), 1996, pp. 2419-2419